Cargando…
Amyloid-ß-directed immunotherapy for Alzheimer's disease
Lannfelt L, Relkin NR, Siemers ER (Uppsala University, Uppsala, Sweden; Weill Cornell Medical College, New York, NY; and Eli Lilly and Co., Indianapolis, IN, USA). Amyloid-ß-directed immunotherapy for Alzheimer’s disease. (Key Symposium). J Intern Med 2014; 275: 284–295. Current treatment options fo...
Autores principales: | Lannfelt, L, Relkin, N R, Siemers, E R |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BlackWell Publishing Ltd
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4238820/ https://www.ncbi.nlm.nih.gov/pubmed/24605809 http://dx.doi.org/10.1111/joim.12168 |
Ejemplares similares
-
Magnetic resonance imaging for monitoring therapeutic response in a transgenic mouse model of Alzheimer’s disease using voxel-based analysis of amyloid plaques
por: Kim, Jae-Hun, et al.
Publicado: (2014) -
Associations of the Lifestyle for Brain Health index with longitudinal cognition and brain amyloid beta in clinically unimpaired older adults: Findings from the Wisconsin Registry for Alzheimer's Prevention
por: Cody, Karly A., et al.
Publicado: (2022) -
Dual Blockade of the Renin-Angiotensin System in Diabetic Nephropathy
por: Ravid, Mordchai
Publicado: (2009) -
Microvascular Complications in Diabetic Erectile Dysfunction: Do we need other alternatives?
por: Vardi, Yoram
Publicado: (2009) -
Painful Diabetic Neuropathy: Advantage of novel drugs over old drugs?
por: Ziegler, Dan
Publicado: (2009)